The biologics contract manufacturing market is projected to attain a robust value of $83.47 billion by 2033, demonstrating promising trends, outlook, and the participation of industry-leading companies such as Datam Intelligence. Biologics are complex biological products that are derived from living organisms, providing innovative solutions for a wide array of diseases. Contract manufacturing plays a […]
